CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 

Healthcare Sector

Biotechnology & Drugs Industry Profitability  


Profitability by Company within Biotechnology & Drugs Industry
Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Avalanche Biotechnologies, Inc. 0 Q - - - -
Abbvie Inc. 2 Q 78 % 27.58 % 19.41 % 119.66 %
American Bio Medica Corp 2 Q 43.26 % - 0.15 % -
Acorda Therapeutics Inc 2 Q 78.73 % - 5.39 % -
Aclaris Therapeutics, Inc. 0 Q - - - -
Actavis Plc 0 Q - - - -
Ocata Therapeutics, Inc. 0 Q - - - -
Adaptimmune Therapeutics Plc 2 Q - - - -
Fennec Pharmaceuticals Inc. 0 Q - - - -
Adma Biologics, Inc. 2 Q - - - -
Adverum Biotechnologies, Inc. 2 Q - - - 16.15 %
Aerie Pharmaceuticals Inc 2 Q - - - -
Agenus Inc 2 Q - - - -
Allergan Plc 2 Q 86.27 % - - 15.74 %
Applied Genetic Technologies Corp 2 Q - 22.52 % 90.68 % -
Alder Biopharmaceuticals Inc 2 Q - - - -
Alliance Bioenergy Plus, Inc. 2 Q - - - -
Amarillo Biosciences Inc 2 Q 76.53 % 5.2 % 6.55 % -
Amarantus Bioscience Holdings, Inc. 0 Q - - - -
Amarantus Bioscience Holdings, Inc. 0 Q - - - -
Amgen Inc. 2 Q 82.38 % 37.02 % - 26.58 %
Albany Molecular Research Inc 2 Q 23.83 % - 4.07 % -
Amyris, Inc. 2 Q 32.71 % 2.41 % 14.72 % -
Aeolus Pharmaceuticals, Inc. 2 Q - - - -
Ampliphi Biosciences Corp 2 Q - - - -
Aptevo Therapeutics Inc. 2 Q 45.22 % - 76.69 % -
Ariad Pharmaceuticals Inc 0 Q - - - -
Arno Therapeutics, Inc 0 Q - - - -
Assembly Biosciences, Inc. 2 Q - - - -
Asterias Biotherapeutics, Inc. 2 Q 94.3 % - - -
Atara Biotherapeutics, Inc. 2 Q - - - -
Kubota Pharmaceutical Holdings Co Ltd 0 Q - - - -
Aviragen Therapeutics, Inc. 2 Q - - - -
Anavex Life Sciences Corp. 2 Q - - - -
Axim Biotechnologies, Inc. 4 Q - - - -
Axovant Sciences Ltd. 2 Q - - - -
Aytu Bioscience, Inc 2 Q 76.79 % - - -
Azurrx Biopharma, Inc. 2 Q - - - -
Brainstorm Cell Therapeutics Inc. 2 Q - - - -
Biocryst Pharmaceuticals Inc 2 Q - - - -
Beesfree, Inc. 0 Q - - - -
U.s. Stem Cell, Inc. 2 Q 71.09 % - 22.41 % -
Premier Biomedical Inc 2 Q - - - -
Biogen Inc. 2 Q 88.1 % 28.03 % 7 % 27.82 %
Immucor Inc 0 Q - - - -
Bluebird Bio, Inc. 2 Q - - - -
Bionovo Inc 0 Q - - - -
Audentes Therapeutics, Inc. 2 Q - - - -
Bohai Pharmaceuticals Group, Inc. 0 Q - - - -
Biota Pharmaceuticals, Inc. 0 Q - - - -
Biopharmx Corp 2 Q 47.06 % - - -
Biotech Products Services & Research, Inc. 2 Q 77.24 % - - -
Biorestorative Therapies, Inc. 2 Q - - - -
Boston Therapeutics, Inc. 2 Q - - - -
Biotime Inc 1 Q 85.38 % - - 65.14 %
Burzynski Research Institute Inc 2 Q - - - -
Cadence Pharmaceuticals Inc 0 Q - - - -
General Cannabis Corp 2 Q 21.95 % - - -
Capricor Therapeutics, Inc. 2 Q - - 67.77 % -
Capstone Therapeutics Corp. 2 Q - - - -
Casi Pharmaceuticals, Inc. 2 Q - - - 21.34 %
Catalyst Biosciences, Inc. 2 Q - - - -
Cellular Biomedicine Group, Inc. 2 Q 39.45 % - - -
China Botanic Pharmaceutical 0 Q - - - -
China Biologic Products Holdings, Inc. 2 Q 66.27 % 39.02 % 28.99 % 22.57 %
Cellcyte Genetics Corp. 0 Q - - - -
Cidara Therapeutics, Inc. 2 Q - - - -
Chromadex Corp. 2 Q 42.64 % - - -
Cardax, Inc. 2 Q 54.27 % - - -
Cen Biotech Inc 2 Q - - - -
Cerecor Inc. 2 Q - - - -
Compugen Ltd 2 Q - - - -
Coherus Biosciences, Inc. 2 Q - - - -
Chelsea Therapeutics International, Ltd. 0 Q - - - -
China Kangtai Cactus Bio-tech, Inc. 0 Q - - - -
Celladon Corporation 0 Q - - - -
United Cannabis Corp 2 Q 44.59 % - - -
Cannabics Pharmaceuticals Inc. 2 Q - - - -
Compass Biotechnologies Inc. 0 Q - - - -
Cohbar, Inc. 2 Q - - - -
Cocrystal Pharma, Inc. 2 Q - - - -
Cortex Pharmaceuticals Inc 0 Q - - - -
Cannapharmarx, Inc. 0 Q - - - -
Curis Inc 2 Q - - - -
Crispr Therapeutics Ag 2 Q - - - -
American Cryostem Corp 2 Q 67.13 % 2.67 % - -
Champions Oncology, Inc. 2 Q - - - -
Ctd Holdings Inc 2 Q 84.06 % - - -
Cellceutix Corp 1 Q - - - -
Cytomx Therapeutics, Inc. 2 Q - - - -
Citius Pharmaceuticals, Inc. 2 Q - - - -
Neuralstem, Inc. 2 Q - - - -
Cel Sci Corp 2 Q - - - -
Cv Sciences, Inc. 2 Q 69.69 % - - -
Cyanotech Corp 2 Q 40.9 % 5.69 % - -
Cytodyn Inc. 2 Q - - - -
Cytrx Corp 2 Q - - - -
Dandrit Biotech Usa, Inc. 1 Q - - - -
Diadexus, Inc. 0 Q - - - -
Diffusion Pharmaceuticals Inc. 2 Q - - - -
Delmar Pharmaceuticals, Inc. 0 Q - - - -
Dimension Therapeutics, Inc. 2 Q - - 23.46 % -
Dna Testing Centers Corp 4 Q - - 6.74 % -
Dendreon Corp 0 Q - - - -
Noho, Inc. 0 Q - - - -
Windtree Therapeutics Inc 0 Q - - - -
Ds Healthcare Group, Inc. 2 Q 58.96 % - - -
Emergent Biosolutions Inc. 2 Q 65.64 % 4.58 % 45.11 % 12.44 %
Edge Therapeutics, Inc. 2 Q - - - -
Eiger Biopharmaceuticals, Inc. 2 Q - - - -
Empowered Products, Inc. 0 Q - - - -
Endonovo Therapeutics, Inc. 2 Q - - - -
Entremed Inc 0 Q - - - -
Entest Biomedical, Inc. 2 Q - - - -
Enumeral Biomedical Holdings, Inc. 2 Q - - - -
Enzon Pharmaceuticals, Inc. 2 Q - 61.77 % 46.15 % 7.94 %
Enzymotec Ltd. 0 Q - - - -
Entia Biosciences, Inc. 4 Q 77.99 % - - -
Eastgate Biotech Corp 0 Q - - - -
Fate Therapeutics Inc 2 Q - - - -
Fennec Pharmaceuticals Inc. 2 Q - - - -
Fulgent Genetics, Inc. 2 Q 59.5 % - - 0.45 %
Foamix Pharmaceuticals Ltd. 2 Q - - - -
Global Future City Holding Inc. 1 Q 64.93 % - - -
Galena Biopharma, Inc. 2 Q - - - -
Gentium S.p.a. 0 Q - - - -
Synageva Biopharma Corp 0 Q - - - -
Gilead Sciences Inc 2 Q 84.23 % 42.98 % - 55.84 %
Glucose Health, Inc. 2 Q 99.2 % - 27.33 % -
Genocea Biosciences, Inc. 2 Q - - - -
Aevi Genomic Medicine, Inc. 2 Q - - - -
Green Planet Bio Engineering Co. Ltd. 2 Q - - - -
Green Meadow Products, Inc. 1 Q 41.67 % - 7.68 % -
Guided Therapeutics Inc 2 Q 5.75 % - 8.05 % -
Genethera Inc 0 Q - - - -
Gtx Inc 2 Q - - - -
Gtx Corp 2 Q 57.13 % 46.6 % - -
Green Vision Biotechnology Corp. 2 Q 38.98 % - - -
Halozyme Therapeutics Inc. 2 Q 76.92 % - 63.93 % -
Hubei Minkang Pharmaceutical Ltd. 0 Q - - - -
Health Discovery Corp 0 Q - - - -
Hemispherx Biopharma Inc 2 Q - - - -
Hedgepath Pharmaceuticals, Inc. 1 Q - - - -
Hyperion Therapeutics Inc 0 Q - - - -
Heska Corp 2 Q 43.48 % 9.14 % - 17.32 %
Hst Global, Inc. 2 Q - - - -
Idera Pharmaceuticals, Inc. 2 Q - - - -
Igi Laboratories, Inc 0 Q - - - -
Intelgenx Technologies Corp. 2 Q 92.1 % - 88.01 % -
Intellect Neurosciences, Inc. 0 Q - - - -
Immudyne, Inc. 2 Q 70.27 % 62.88 % 4.97 % -
Immage Biotherapeutics Corp. 0 Q - - - -
Immune Therapeutics, Inc. 2 Q - - - -
Integrated Biopharma Inc 2 Q 15.17 % 14.68 % - -
Innovus Pharmaceuticals, Inc. 2 Q - - - -
Renovacare, Inc. 2 Q - - - -
Jounce Therapeutics, inc. 2 Q - - - -
Juno Therapeutics, Inc. 2 Q - - 61.08 % -
Cadus Corp 2 Q - - - -
Kite Pharma, Inc. 2 Q - - - -
Lion Biotechnologies, Inc. 1 Q - - - -
Lescarden Inc 0 Q - - - -
Atyr Pharma Inc 2 Q - - - -
Lixte Biotechnology Holdings, Inc. 2 Q - - - -
La Jolla Pharmaceutical Co 2 Q - - - -
Lightlake Therapeutics Inc. 0 Q - - - -
Lazuriton Nano Biotechnology (u.s.a.) Inc. 2 Q - - - -
Apollo Endosurgery, inc. 2 Q 61.27 % - - -
Mateon Therapeutics Inc 0 Q - - - -
Mabvax Therapeutics Holdings, Inc. 2 Q - - - -
Multicell Technologies, Inc. 0 Q - - - -
Microchannel Technologies Corp 0 Q - - - -
Medgenics, Inc. 0 Q - - - -
Manhattan Pharmaceuticals Inc 0 Q - - - -
Mirna Therapeutics, Inc. 2 Q - - - -
Micromet, Inc. 0 Q - - - -
Mj Pharmaceuticals Inc. 0 Q - - - -
Momenta Pharmaceuticals Inc 2 Q - - - -
Mount Tam Biotechnologies, Inc. 2 Q - - - -
Marina Biotech, Inc. 2 Q - - - -
Mymetics Corp 2 Q - - 27.13 % -
Myokardia Inc 2 Q - - - -
Myrexis, Inc. 0 Q - - - -
Nascent Biotech Inc. 2 Q - - - 19.88 %
Neurocrine Biosciences Inc 2 Q 99.04 % - - -
Caladrius Biosciences, Inc. 2 Q - - - 92.53 %
Northsight Capital, Inc. 2 Q - - 38.93 % -
Nexus Biopharma Inc 0 Q - - - -
Nantkwest, Inc. 2 Q - - - -
Nile Therapeutics, Inc. 0 Q - - - -
Nanoantibiotics, Inc. 0 Q - - - -
Nutra Pharma Corp. 2 Q 66.88 % - - -
Nanostring Technologies Inc 0 Q - - - -
Intellia Therapeutics, Inc. 2 Q - - - -
Nbty Inc 0 Q - - - -
Nugene International, Inc. 0 Q - - - -
Nutrastar International Inc. 0 Q - - - -
Novavax Inc 2 Q - - - -
N-viro International Corporation 0 Q - - - -
Obalon Therapeutics Inc 2 Q 49.57 % - - -
Oncbiomune Pharmaceuticals, Inc 2 Q 36.64 % - - -
Oncocyte Corp 2 Q - - - -
Spark Therapeutics, Inc. 2 Q - - - -
Oncobiologics, Inc. 2 Q - - 19.41 % -
Organovo Holdings, Inc. 2 Q 69.6 % - - -
Ophthalix, Inc. 2 Q - - - -
Opiant Pharmaceuticals, Inc. 1 Q - - - 2471.16 %
Avant Diagnostics, Inc. 0 Q - - - -
Orgenesis Inc. 2 Q 50.91 % 24.33 % - 11.45 %
Osiris Therapeutics, Inc. 0 Q - - - -
Oncovista Innovative Therapies, Inc 0 Q - - - -
Mateon Therapeutics Inc 2 Q - - - -
Gt Biopharma, Inc. 2 Q - - - -
Prolor Biotech, Inc. 0 Q - - - -
Procyon Corporation 1 Q 72.05 % - - -
Pdl Biopharma, Inc. 2 Q 96.86 % 42.02 % 24.4 % 16.99 %
Quint Media Inc. 0 Q - - - -
Protokinetix, Inc. 2 Q - - - -
Pulse Biosciences, Inc. 2 Q - - - -
Protalix Biotherapeutics, Inc. 1 Q 27.73 % - - -
Pharmacyte Biotech, Inc. 2 Q - - - -
Proteon Therapeutics Inc 2 Q - - - -
Pluristem Therapeutics Inc 2 Q - - - -
Proteo Inc 1 Q - - - -
Protagonist Therapeutics, Inc 2 Q - - - -
Proteostasis Therapeutics, Inc. 2 Q - - - -
Pulmatrix, Inc. 2 Q - - - -
Pivot Pharmaceuticals Inc. 2 Q - - - -
Qiagen Nv 0 Q - - - -
Quint Media Inc. 0 Q - - - -
Rasna Therapeutics Inc. 0 Q - - - -
Rich Pharmaceuticals, Inc. 1 Q - - - -
Regenocell Therapeutics, Inc. 0 Q - - - -
Receptos, Inc. 0 Q - - - -
Ridgefield Acquisition Corp 2 Q - - - -
Restorgenex Corp 0 Q - - - -
Regen Biopharma Inc 2 Q - - - -
Regado Biosciences Inc 0 Q - - - -
Repligen Corp 2 Q 57.06 % 26 % 38.65 % 10.07 %
Regenxbio Inc. 2 Q 79.93 % - - -
Regenerx Biopharmaceuticals Inc 2 Q - - - -
Relmada Therapeutics, Inc. 1 Q - - - -
Repros Therapeutics Inc. 2 Q - - - -
Respirerx Pharmaceuticals Inc. 2 Q - - - -
Aytu Bioscience, Inc. 0 Q - - - -
Ruthigen, Inc. 0 Q - - - -
Radient Pharmaceuticals Corp 0 Q - - - -
Strongbridge Biopharma Plc 2 Q 75.34 % - - -
Sangui Biotech International Inc 1 Q - - - -
Seattle Genetics Inc 2 Q 92.56 % - - -
Sangamo Therapeutics, Inc 1 Q - - - -
Shengtai Pharmaceutical, Inc. 0 Q - - - -
Skinovation Pharmaceutical Inc 2 Q - - - -
Skinvisible Inc 2 Q - - 3.93 % -
Sun Biopharma, Inc. 2 Q - - - -
Syndax Pharmaceuticals Inc 2 Q - - - -
Soligenix, Inc. 2 Q 31.67 % - - -
Senesco Technologies Inc 0 Q - - - -
Senesco Technologies Inc 0 Q - - - -
Microbot Medical Inc. 2 Q - - - -
Sunwin Stevia International, Inc. 0 Q - - - -
Intellicell Biosciences, Inc. 0 Q - - - -
Savient Pharmaceuticals Inc 0 Q - - - -
Sevion Therapeutics, Inc. 1 Q - - - -
Tobira Therapeutics, Inc. 0 Q - - - -
Tracon Pharmaceuticals, Inc. 2 Q - - - -
Bio-techne Corp 2 Q 70.77 % 20.5 % 20.29 % 8.35 %
Telik Inc 0 Q - - - -
Mabvax Therapeutics Holdings, Inc. 0 Q - - - -
Tongli Pharmaceuticals (usa), Inc. 0 Q - - - -
Tg Therapeutics, Inc. 2 Q - - - -
Tg Therapeutics, Inc. 0 Q - - - -
Twinlab Consolidated Holdings, Inc. 2 Q 26.39 % - - -
Teligent, Inc. 2 Q 43.66 % - - -
Targeted Medical Pharma, Inc. 0 Q - - - -
Targacept Inc 0 Q - - - -
Trovagene, Inc. 2 Q - - - -
Therapeutic Solutions International, Inc. 2 Q 69.53 % - - -
Trius Therapeutics Inc 0 Q - - - -
Taxus Pharmaceuticals Holdings, Inc. 1 Q - - - -
Tyme Technologies, Inc. 1 Q - - - -
Uluru Inc. 2 Q 92 % - - -
United Bancshares Inc 0 Q - - - -
Vitality Biopharma, Inc. 2 Q 24.25 % - - -
Vericel Corp 2 Q 54.76 % - - -
Vical Inc 2 Q 53.17 % - 1.46 % -
Viropharma Inc 0 Q - - - -
Vistagen Therapeutics, Inc. 2 Q - - - -
Vistagen Therapeutics, Inc. 0 Q - - - -
Ventrus Biosciences Inc 0 Q - - - -
Voyager Therapeutics, Inc. 2 Q - - - 16.52 %
Warner Chilcott Plc 0 Q - - - -
Windtree Therapeutics Inc 2 Q - - - -
Weikang Bio-technology Group Co., Inc. 0 Q - - - -
Wave Life Sciences Ltd. 1 Q - - - -
Xenetic Biosciences, Inc. 2 Q - - - -
Acceleron Pharma Inc 2 Q - - - -
Xstelos Holdings, Inc. 0 Q - - - -
Profitability
Biotechnology & Drugs Industry
Gross margin improved to 82.29 % in 2. Quarter 2017 from 81.53 % in previous quarter, now Ranking #0 and ranking within sector #0.
Net margin for Biotechnology & Drugs Industry is 20.1 % above industry average.

More on Biotechnology & Drugs Industry Profitability

Return on equity in 2. Quarter 2017 was 22.69 %, Total Ranking # and ranking within sector #.

More on Biotechnology & Drugs Industry Cash flow
More on Biotechnology & Drugs Industry ROE
You need to upgrade your Flash Player







Cardiovascular Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Economy

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks

Event Calendar

ZUMZ's Report

ZUMZ's News

ZUMZ's Revenue Growth

ZUMZ's Description

Fundamentals

Charts & Quotes

ZUMZ's ROI

Suppliers

Competition

Customers & Markets

ZUMZ's Profitability

ZUMZ's Growth

Segment Results

ZUMZ's PE

ZUMZ's Dividends

ZUMZ's Quick Ratio

 Screening


Share Price Performance

Growth Rates Ranking

Profitability

Valuation

Dividend

Financial Strength

Efficiency Ranking

Expectations

Mgmnt. Effectivness

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

 News


At a Glance

Stocks

Economy

Industries

Other

 Help


Sitemap

Advertise

About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com